294 related articles for article (PubMed ID: 26668261)
1. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.
Johnson TL; Waack U; Smith S; Mobley H; Sandkvist M
J Bacteriol; 2015 Dec; 198(4):711-9. PubMed ID: 26668261
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
Elhosseiny NM; Elhezawy NB; Attia AS
Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
[TBL] [Abstract][Full Text] [Related]
4. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.
Elhosseiny NM; El-Tayeb OM; Yassin AS; Lory S; Attia AS
Int J Med Microbiol; 2016 Dec; 306(8):633-641. PubMed ID: 27713027
[TBL] [Abstract][Full Text] [Related]
5. InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.
Jackson-Litteken CD; Di Venanzio G; Le NH; Scott NE; Djahanschiri B; Distel JS; Pardue EJ; Ebersberger I; Feldman MF
mBio; 2022 Jun; 13(3):e0025822. PubMed ID: 35638734
[TBL] [Abstract][Full Text] [Related]
6. Genomic and functional analysis of the type VI secretion system in Acinetobacter.
Weber BS; Miyata ST; Iwashkiw JA; Mortensen BL; Skaar EP; Pukatzki S; Feldman MF
PLoS One; 2013; 8(1):e55142. PubMed ID: 23365692
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung.
Wang N; Ozer EA; Mandel MJ; Hauser AR
mBio; 2014 Jun; 5(3):e01163-14. PubMed ID: 24895306
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii.
Yoon EJ; Balloy V; Fiette L; Chignard M; Courvalin P; Grillot-Courvalin C
mBio; 2016 May; 7(3):. PubMed ID: 27247231
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity.
Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286
[No Abstract] [Full Text] [Related]
10. Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii.
Saranathan R; Pagal S; Sawant AR; Tomar A; Madhangi M; Sah S; Satti A; Arunkumar KP; Prashanth K
Virulence; 2017 Oct; 8(7):1316-1334. PubMed ID: 28436748
[TBL] [Abstract][Full Text] [Related]
11. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
[TBL] [Abstract][Full Text] [Related]
12. H-NS plays a role in expression of Acinetobacter baumannii virulence features.
Eijkelkamp BA; Stroeher UH; Hassan KA; Elbourne LD; Paulsen IT; Brown MH
Infect Immun; 2013 Jul; 81(7):2574-83. PubMed ID: 23649094
[TBL] [Abstract][Full Text] [Related]
13. Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia.
Kim J; Lee JY; Lee H; Choi JY; Kim DH; Wi YM; Peck KR; Ko KS
Virulence; 2017 Oct; 8(7):1378-1389. PubMed ID: 28448786
[TBL] [Abstract][Full Text] [Related]
14. CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.
Waack U; Warnock M; Yee A; Huttinger Z; Smith S; Kumar A; Deroux A; Ginsburg D; Mobley HLT; Lawrence DA; Sandkvist M
mBio; 2018 Dec; 9(6):. PubMed ID: 30563903
[TBL] [Abstract][Full Text] [Related]
15. Functional features of TonB energy transduction systems of Acinetobacter baumannii.
Zimbler DL; Arivett BA; Beckett AC; Menke SM; Actis LA
Infect Immun; 2013 Sep; 81(9):3382-94. PubMed ID: 23817614
[TBL] [Abstract][Full Text] [Related]
16. The Secrets of Acinetobacter Secretion.
Weber BS; Kinsella RL; Harding CM; Feldman MF
Trends Microbiol; 2017 Jul; 25(7):532-545. PubMed ID: 28216293
[TBL] [Abstract][Full Text] [Related]
17. Characterization of RelA in Acinetobacter baumannii.
Pérez-Varela M; Tierney ARP; Kim JS; Vázquez-Torres A; Rather P
J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229531
[TBL] [Abstract][Full Text] [Related]
18. The success of acinetobacter species; genetic, metabolic and virulence attributes.
Peleg AY; de Breij A; Adams MD; Cerqueira GM; Mocali S; Galardini M; Nibbering PH; Earl AM; Ward DV; Paterson DL; Seifert H; Dijkshoorn L
PLoS One; 2012; 7(10):e46984. PubMed ID: 23144699
[TBL] [Abstract][Full Text] [Related]
19. Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
Sutton KA; Breen J; MacDonald U; Beanan JM; Olson R; Russo TA; Schultz LW; Umland TC
Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1736-44. PubMed ID: 26249354
[TBL] [Abstract][Full Text] [Related]
20. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence.
Harding CM; Kinsella RL; Palmer LD; Skaar EP; Feldman MF
PLoS Pathog; 2016 Jan; 12(1):e1005391. PubMed ID: 26764912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
